TL;DR: A 2026 BMC Medicine study of UK Biobank adults linked adversity in both childhood and adulthood to higher frailty, older metabolomic age profiles, lower grip strength, and some telomere differences, with the clearest associations in people reporting multiple adverse events. Key Findings Large cohort: The study analyzed up to 153,557 middle-aged and older UK …
TL;DR: A 2026 study in Nature Communications found that self-administered finger-prick blood tests for phosphorylated tau 217 (p-tau217), an Alzheimer’s tau marker, and glial fibrillary acidic protein (GFAP), an astrocyte-injury marker, correlated with cognition and function in older adults. Key Findings Remote sampling: Participants used capillary finger-prick blood collection rather than standard clinic-based venous blood …
TL;DR: A 2026 article-in-press study in Alzheimer’s Research & Therapy found that olfactory-region MRI radiomics, a method that turns brain scans into quantitative texture and shape features, linked blood pTau217, a tau-related Alzheimer’s disease biomarker, with cognitive impairment across three cohorts. Key Findings Three Alzheimer’s cohorts were matched: Researchers matched 122 Alzheimer’s disease (AD) patients …
TL;DR: A 2026 study in the Journal of the American Heart Association followed 1,882 stroke-free women from the Framingham Heart Study for a median of 18 years and found that having three or more live births was associated with a reduced risk of clinical stroke and lower MRI markers of vascular brain injury — the …
TL;DR: A 2026 study in JAMA Network Open analyzed Medicare claims for adults 66+ from 2008 to 2021 and found that cognition-altering medications — antipsychotics, benzodiazepines, hypnotics, anticholinergics — were disproportionately initiated in emergency rooms, hospitals, and skilled nursing facilities rather than doctors’ offices, especially in dementia patients (43% of antipsychotic starts vs 22% of …
TL;DR: A 2026 medRxiv preprint tested SimulAD, an Alzheimer’s disease progression simulator, and reported that it reproduced mean amyloid-clearance results within 5% error across six major phase III anti-amyloid trials while also separating positive trials from null trials in retrospective power analyses. Key Findings Six phase III trials: Researchers retrospectively simulated TRAILBLAZER-ALZ2, CLARITY AD, EMERGE, …
TL;DR: A 2026 study in JAMA Network Open tracked 1,338 older adults from the Rush Memory and Aging Project for up to 19 years using objective wrist-actigraphy and found that each additional hour of daytime napping per day was linked to ~13% higher mortality, each extra nap per day to ~7% higher mortality, and morning …
TL;DR: A 2026 study in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences measured a monocyte-specific DNA methylation clock (MonoDNAmAge) in 440 women with and without HIV, and found that accelerated monocyte epigenetic aging was specifically linked to non-somatic depressive symptoms (anhedonia, hopelessness, cognitive impacts) but not to broader depression severity, supporting …
Brain Age MRI Mapped Stroke Recovery in 501 Patients TL;DR: A Lancet Digital Health ENIGMA study found that larger stroke lesions made the damaged hemisphere look biologically older, while severe motor impairment was linked to younger-appearing contralesional networks, likely reflecting compensation. Key Findings 501 chronic stroke survivors: The ENIGMA Stroke Recovery Working Group dataset included …
Vigorous Activity Linked to Lower Dementia Risk in UK Biobank TL;DR: In UK Biobank accelerometer data, the vigorous share of daily movement accounted for 32% of dementia’s population-attributable fraction versus just 8% for total activity volume — suggesting brief breathless bursts carry brain-health information that step counts miss. Key Findings Dementia favored intensity over volume: …
